H. Debinski

发表

Effect of intestinal resection on quality of life in Crohn's disease.

Steven J Brown, M. Kamm, W. Selby, 2015, Journal of Crohn's & colitis.

Electrogastrography in chronic intestinal pseudoobstruction

M. Kamm, P. Milla, H. Debinski, 1996, Digestive Diseases and Sciences.

Photodynamic therapy for polyps in familial adenomatous polyposis--a pilot study.

A. Spigelman, J. Reguła, H. Messmann, 1995, European journal of cancer.

Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high‐risk patients – a POCER study analysis

M. Kamm, W. Selby, J. Andrews, 2015, Alimentary pharmacology & therapeutics.

Crohn's disease management after intestinal resection: a randomised trial

Steven J Brown, M. Kamm, W. Selby, 2015, The Lancet.

Effect of sulindac on small polyps in familial adenomatous polyposis

A. Spigelman, H. Debinski, R. Phillips, 1995, The Lancet.

Upper intestinal surveillance in familial adenomatous polyposis.

A. Spigelman, H. Debinski, R. Phillips, 1995, European journal of cancer.

Localization of uridine 5'-diphosphate-glucuronosyltransferase in human liver injury.

J. Danks, P. Desmond, H. Debinski, 1995, Gastroenterology.

p53 and K‐ras status in duodenal adenomas in familial adenomatous polyposis

A. Spigelman, I. Talbot, N. Lemoine, 1997, British Journal of Surgery.

OP023 Optimising post-operative Crohn's disease management: Best drug therapy alone versus endoscopic monitoring, disease evolution, and faecal calprotectin monitoring. The POCER study

M. Kamm, W. Selby, J. Andrews, 2014 .

Surveillance of ampullary adenomas in familial adenomatous polyposis

A. Spigelman, I. Talbot, H. Debinski, 1994, The Lancet.

Anti-TNF Therapeutic Drug Monitoring in Postoperative Crohn’s Disease

Steven J Brown, M. Kamm, W. Selby, 2018, Journal of Crohn's & colitis.

Udp‐Glucuronosyltransferase In Gilbert'S Syndrome

P. Desmond, A. Dhillon, H. Debinski, 1996, Pathology.

DOP064 Faecal calprotectin is superior to faecal lactoferrin and S100A12

J. Keenan, M. Kamm, W. Selby, 2014 .

Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery.

Steven J Brown, M. Kamm, W. Selby, 2015, Gastroenterology.

Colorectal polyp counts and cancer risk in familial adenomatous polyposis.

A. Spigelman, S. Love, H. Debinski, 1996, Gastroenterology.

Molecular Pathologic Analysis Enhances the Diagnosis and Management of Muir-Torre Syndrome and Gives Insight Into Its Underlying Molecular Pathogenesis

M. Southey, K. Aittomäki, M. Young, 2001, The American journal of surgical pathology.

1161 Adalimumab Prevents Post-Operative Crohn's Disease Recurrence, and is Superior to Thiopurines: Early Results From the POCER Study

Steven J Brown, M. Kamm, W. Selby, 2012 .

312 The First Validated Post-Operative Endoscopic Crohns Disease Index: The POCER Index. Identification of Key Endoscopic Prognostic Factors

Steven J Brown, M. Kamm, W. Selby, 2016 .

Su2092 Clinical Risk Stratification Predicts Development of Endoscopic Recurrence After Crohn's Disease Surgery: Early Results From the POCER Study

Steven J Brown, M. Kamm, W. Selby, 2012 .

998 Faecal Calprotectin Is Superior to Faecal Lactoferrin and S100A12 As a Surrogate Marker for Post-Operative Crohn's Disease Endoscopic Recurrence. Prospective Longitudinal Endoscopic Validation. Results From the POCER Study

Steven J Brown, J. Keenan, M. Kamm, 2014 .

925j Optimising post-operative Crohn's disease management: best drug therapy alone versus colonoscopic monitoring with treatment step-up. The POCER study.

Steven J Brown, M. Kamm, W. Selby, 2013 .

P342 Adalimumab prevents post-operative Crohn's disease recurrence and is superior to thiopurines: E

Steven J Brown, W. Selby, J. Andrews, 2012 .

Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials.

A. Ananthakrishnan, J. Reguła, D. Rubin, 2021, The lancet. Gastroenterology & hepatology.

UDP glucuronosyltransferase in the cirrhotic rat liver

P. Mackenzie, J. Danks, T. Tephly, 1996, Journal of gastroenterology and hepatology.

Degos' disease with delayed involvement of the gastrointestinal tract

K. Subramaniam, H. Debinski, P. Heenan, 2008, The Australasian journal of dermatology.

EPr study of copper(I) sulphide

H. Debinski, J. Kuriata, L. Sadłowski, 1986 .

Diagnosis and Outcome of Small Bowel Tumors Found by Capsule Endoscopy: A Three-Center Australian Experience

M. Appleyard, W. Selby, H. Debinski, 2006, The American Journal of Gastroenterology.

Serologic antibodies in relation to outcome in postoperative Crohn's disease

Steven J Brown, M. Kamm, W. Selby, 2017, Journal of gastroenterology and hepatology.

Adalimumab prevents post-operative Crohn's disease recurrence, and is superior to thiopurines: early results from the POCER study

Steven J Brown, M. Kamm, J. Andrews, 2012 .

Increased Sympathetic Nervous Activity and the Effects of Its Inhibition with Clonidine in Alcoholic Cirrhosis

G. Jennings, M. Esler, B. Crotty, 1992, Annals of Internal Medicine.

Crohn's disease management after intestinal resection: a randomised trial

Steven J Brown, W. Selby, J. Andrews, 2015, The Lancet.